Effect of the selective noradrenergic reuptake inhibitor reboxetine on the firing activity of noradrenaline and serotonin neurons

No abstract is available for this paper.

• Publication year

  2001

• Venue

  European Journal of Neuroscience

• Publication date

  2001-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1046/j.0953-816x.2001.01583.xPMID 11422448
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serotonin-norepinephrine interactions: a voltammetric study on the effect of serotonin receptor stimulation followed in the N. raphe dorsalis and the Locus coeruleus of the rat

  2005cited by this paper
• Evidence that 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptors

  2005cited by this paper
• Progressive attenuation of the firing activity of locus coeruleus noradrenergic neurons by sustained administration of selective serotonin reuptake inhibitors.

  2000cited by this paper
• Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor.

  2000cited by this paper
• Progressive attenuation of the firing activity of locus coeruleus noradrenergic neurons by sustained administration of selective serotonin reuptake inhibitors

  2000cited by this paper
• Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.

  2000cited by this paper
• Dependence of serotonin release in the locus coeruleus on dorsal raphe neuronal activity

  1999cited by this paper
• Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain

  1999cited by this paper
• Venlafaxine: Discrepancy between in vivo 5‐HT and NE reuptake blockade and affinity for reuptake sites

  1999cited by this paper
• Modulation of noradrenergic neuronal firing by selective serotonin reuptake blockers

  1999cited by this paper
• Effect of acute, short- and long-term milnacipran administration on rat locus coeruleus noradrenergic and dorsal raphe serotonergic neurons.

  1998cited by this paper
• Somatodendritic α2‐Adrenoceptors in the Locus Coeruleus Are Involved in the In Vivo Modulation of Cortical Noradrenaline Release by the Antidepressant Desipramine

  1998cited by this paper
• Effect of the reversible monoamine oxidase-A inhibitor befloxatone on the rat 5-hydroxytryptamine neurotransmission.

  1998cited by this paper
• Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5‐hydroxtryptamine system

  1997cited by this paper
• Blockade of the serotonin and norepinephrine uptake processes by duloxetine: in vitro and in vivo studies in the rat brain.

  1996cited by this paper
• Biological processes in depression: An updated review and integration.

  1995cited by this paper
• Lack of Cross-Tolerance for Hypophagia Induced by DOI versus m-CPP Suggests Separate Mediation by 5-HT2A and 5-HT2C Receptors, Respectively

  1995cited by this paper
• Excitation of noradrenergic cell firing by 5-hydroxytryptamine1A agonists correlates with dopamine antagonist properties.

  1994cited by this paper
• Current advances and trends in the treatment of depression.

  1994cited by this paper
• In vivo electrophysiological evidence for tonic activation by endogenous noradrenaline of α2-adrenoceptors on 5-hydroxytryptamine terminals in the rat hippocampus

  1993cited by this paper
• A 5-hydroxytryptamine2 agonist augments gamma-aminobutyric acid and excitatory amino acid inputs to noradrenergic locus coeruleus neurons.

  1993cited by this paper
• Effects of long-term desipramine administration on noradrenergic neurotransmission: electrophysiological studies in the rat brain.

  1991cited by this paper
• Serotonin selectively attenuates glutamate-evoked activation of noradrenergic locus coeruleus neurons

  1991cited by this paper
• Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. III. Evidence for the physiological role of terminalα2-adrenergic autoreceptors

  1989cited by this paper
• Chronic electroconvulsive shock and desimipramine reduce the degree of inhibition by 5-HT and carbachol of forskolin-stimulated adenylate cyclase in rat hippocampal membranes.

  1988cited by this paper
• Spread-sheet analysis in pharmacokinetic simulations

  1986cited by this paper
• Reduced peripheral presynaptic adrenoceptor sensitivity following chronic antidepressant treatment in rats

  1985cited by this paper
• Serotoninergic but not noradrenergic neurons in rat central nervous system adapt to long-term treatment with monoamine oxidase inhibitors.

  1985cited by this paper
• Idazoxan (RX 781094) selectively antagonizes α2-adrenoceptors on rat central neurons

  1984cited by this paper
• Idazoxan (RX 781094) selectively antagonizes alpha 2-adrenoceptors on rat central neurons.

  1984cited by this paper
• Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices.

  1983cited by this paper
• Electrophysiological demonstration of both α2-agonist and antagonist properties of RX 781094☆

  1983cited by this paper
• Electrophysiological demonstration of both alpha 2-agonist and antagonist properties of RX 781094.

  1983cited by this paper
• Intracellular identification of central noradrenergic and serotonergic neurons by a new double labeling procedure

  1982influential reference
• Presnyaptic noradrenergic regulation during depression and antidepressant drug treatment

  1980cited by this paper
• Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists.

  1980cited by this paper
• Functional evidence for subsensitivity of noradrenergic alpha 2 receptors after chronic desipramine treatment.

  1980cited by this paper
• Effects of chronic desipramine treatment on rat brain noradrenergic responses to alpha-adrenergic drugs.

  1980cited by this paper
• Effect of chronic tricylic antidepressant treatment on the serotoninergic autoreceptor: a microiontophoretic study in the rat.

  1980cited by this paper
• Feedback inhibition of brain noradrenaline neurons by tricyclic antidepressants: alpha-receptor mediation.

  1978cited by this paper
• Presynaptic alpha-receptor subsensitivity after long-term antidepressant treatment.

  1978cited by this paper
• Locus coeruleus-to-dorsal raphe input examined by electrophysiological and morphological methods.

  1977cited by this paper
• Evidence for norepinephrine-mediated collateral inhibition of locus coeruleus neurons.

  1977cited by this paper
• Inhibition of both noradrenergic and serotonergic neurons in brain by the alpha-adrenergic agonist clonidine.

  1975cited by this paper
• Projections of the nucleus locus coeruleus in the albino rat.

  1969cited by this paper

• The monoaminergic systems as drivers of Alzheimer's disease pathophysiology and symptomatology.

  2026cites this paper
• Noradrenergic therapies in neurodegenerative disease: from symptomatic to disease modifying therapy?

  2025cites this paper
• AMPA receptors modulate enhanced dopamine neuronal activity induced by the combined administration of venlafaxine and brexpiprazole

  2024cites this paper
• Neurobiological Underpinnings of Hyperarousal in Depression: A Comprehensive Review

  2024cites this paper
• Neuroprotective actions of norepinephrine in neurological diseases

  2024cites this paper
• Ketamine promptly normalizes excess norepinephrine and enhances dopamine neuronal activity in Wistar Kyoto rats

  2023cites this paper
• Effectiveness Of Atomoxetine For Cognitive Function In Methamphetamine Dependent Patients; A Randomized Controlled Trial

  2022cites this paper
• The noradrenergic agent reboxetine plus the antimuscarinic hyoscine butylbromide reduces sleep apnoea severity: a double‐blind, placebo‐controlled, randomised crossover trial

  2021cites this paper
• Investigating the Potential Role of Serotonin-2B Receptor Antagonism in the Neuronal Actions of Adjunctive Aripiprazole

  2020cites this paper
• Triple reuptake inhibition of serotonin, norepinephrine, and dopamine increases the tonic activation of α2-adrenoceptors in the rat hippocampus and dopamine levels in the nucleus accumbens.

  2020cites this paper
• Pupillary and behavioral markers of alerting and orienting: An individual difference approach.

  2020cites this paper
• Atomoxetine Efficacy in Methamphetamine Dependence during Methadone Maintenance Therapy.

  2019cites this paper
• Stimulation of Vagus By Phenylephrine Increases the Efficiency and Safety of Antidepressants and Anti-Epileptics

  2019cites this paper
• Investigation of the Mechanisms of Action of Ketamine on the Monoamine Systems: Electrophysiological Studies on the Rat Brain

  2019cites this paper
• Drugs for Neuropsychiatric Disorders

  2019cites this paper
• Role of Serotonin-2A Receptors in Pathophysiology and Treatment of Depression

  2018cites this paper
• Opioid and noradrenergic contributions of tapentadol to the inhibition of locus coeruleus neurons in the streptozotocin rat model of polyneuropathic pain

  2018influential citation
• Mechanisms underlying anticonvulsant and proconvulsant actions of norepinephrine

  2018cites this paper
• Neurobiological Bases of the Use of Atypical Antipsychotics in Treatment-Resistant Major Depressive Disorder

  2018cites this paper
• Computational Model of Antidepressant Response Heterogeneity as Multi-pathway Neuroadaptation

  2017cites this paper
• Is the Noradrenergic Symptom Cluster a Valid Construct in Adjunctive Treatment of Major Depressive Disorder?

  2017cites this paper
• ANTIDEPRESSANTS IN RELATION TO NEUROCHEMICAL AND BEHAVIORAL EFFECTS OF NICOTINE ADMINISTRATION AND SUBSEQUENT WITHDRAWAL

  2015cites this paper
• The Antidepressant Treatment Response Index as a Predictor of Reboxetine Treatment Outcome in Major Depressive Disorder

  2015cites this paper
• The vigilance regulation model of affective disorders and ADHD.

  2014cites this paper
• Plasticity of Vagal Origin: Identification and Characterization of a Novel Form of Neural Plasticity in Respiratory Motor Control

  2014cites this paper
• Rational site-directed pharmacotherapy for major depressive disorder.

  2014cites this paper
• L-DOPA modifies the antidepressant-like effects of reboxetine and fluoxetine in rats.

  2013influential citation
• Noradrenergic versus dopaminergic modulation of impulsivity, attention and monitoring behaviour in rats performing the stop-signal task

  2013cites this paper
• Intermittent swim stress causes Morris water maze performance deficits in a massed-learning trial procedure that are exacerbated by reboxetine.

  2013cites this paper
• Monoaminergic modulation of behavioural and electrophysiological indices of error processing

  2013cites this paper
• PATHOPHYSIOLOGY OF MOOD DISORDERS: NORADRENERGIC MECHANISMS

  2013cites this paper
• Chapter 11 – Drugs for Neuropsychiatric Disorders

  2013cites this paper
• Effect of tapentadol on neurons in the locus coeruleus.

  2013cites this paper
• Reboxetine in clinical practice: a review.

  2012cites this paper
• Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder: From Cells to Circuits

  2012cites this paper
• Improved preclinical cardiovascular therapeutic indices with long-term inhibition of norepinephrine reuptake using reboxetine.

  2012cites this paper
• Architecture of the Cerebral Cortex

  2012cites this paper
• Noradrenergic Dysfunction in Depression and Suicide

  2012cites this paper
• Effets neurophysiologiques de la stimulation du nerf vague : implication dans le traitement de la dépression résistante et optimisation des paramètres de stimulation

  2012influential citation
• Alterations of monoaminergic systems by sustained triple reuptake inhibition

  2012influential citation
• Effets antalgiques des antidépresseurs monoaminergiques : de la dépression à la neuropathie : approche préclinique

  2012cites this paper
• Chronic desipramine treatment alters tyrosine hydroxylase but not norepinephrine transporter immunoreactivity in norepinephrine axons in the rat prefrontal cortex.

  2011cites this paper
• Locus coeruleus and dorsal raphe neuron activity and response to acute antidepressant administration in a rat model of Parkinson's disease.

  2011influential citation
• Electrophysiological Studies on the Impact of Repeated Electroconvulsive Shocks on Catecholamine Systems in the Rat Brain

  2011cites this paper
• Impact of Medications Used in the Treatment of Mood Disorders on Monoaminergic Systems

  2011cites this paper
• Einfluss selektiver Noradrenalin-Wiederaufnahmehemmung auf die Kreislaufregulation unter Schwerkraftbelastung bei Gesunden

  2011cites this paper
• Neuroanatomical targets of reboxetine and bupropion as revealed by pharmacological magnetic resonance imaging

  2011cites this paper
• Characterization of the electrophysiological properties of triple reuptake inhibitors on monoaminergic neurons.

  2011cites this paper
• Monoaminergic Antidepressants in the Relief of Pain: Potential Therapeutic Utility of Triple Reuptake Inhibitors (TRIs)

  2011cites this paper
• Relevance of Norepinephrine–Dopamine Interactions in the Treatment of Major Depressive Disorder

  2010influential citation
• Human locus coeruleus neurons express the GABA(A) receptor gamma2 subunit gene and produce benzodiazepine binding.

  2010cites this paper
• The Role of the Noradrenergic System in the Exploration–Exploitation Trade-Off: A Psychopharmacological Study

  2010cites this paper
• Electrophysiological effects of the co-administration of escitalopram and bupropion on rat serotonin and norepinephrine neurons

  2010cites this paper
• Serotonergic mechanisms on breathing modulation in the rat locus coeruleus

  2010cites this paper
• Effects of acute and sustained administration of the catecholamine reuptake inhibitor nomifensine on the firing activity of 2 J monoaminergic neurons

  2010cites this paper
• The locus coeruleus and central chemosensitivity.

  2010cites this paper
• Genetic Deletion of Fatty Acid Amide Hydrolase Alters Emotional Behavior and Serotonergic Transmission in the Dorsal Raphe, Prefrontal Cortex, and Hippocampus

  2010cites this paper
• Beneficial effects of desipramine on cognitive function of chronically stressed rats are mediated by alpha1-adrenergic receptors in medial prefrontal cortex.

  2010cites this paper
• REVIEW: Norepinephrine and stimulant addiction

  2009cites this paper
• Einfluss weiblicher Sexualhormone auf die Kreislaufregulation unter Noradrenalin-Wiederaufnahmehemmung

  2009cites this paper
• Brain norepinephrine system as a target for antidepressant and mood stabilizing medications.

  2009cites this paper
• Antidepressant drugs with differing pharmacological actions decrease activity of locus coeruleus neurons.

  2009cites this paper
• Atomoxetine Attenuates Dextroamphetamine Effects in Humans

  2009cites this paper
• 5‐HT1A Activation Counteracts Cardiovascular But Not Hypophagic Effects of Sibutramine in Rats

  2009cites this paper
• The cannabinoid CB1 receptor and the endocannabinoid anandamide: possible antidepressant targets

  2008cites this paper
• Sustained administration of bupropion alters the neuronal activity of serotonin, norepinephrine but not dopamine neurons in the rat brain.

  2008cites this paper
• Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression.

  2008cites this paper
• Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions.

  2008cites this paper
• Chronic Unpredictable Stress Induces a Cognitive Deficit and Anxiety-Like Behavior in Rats that is Prevented by Chronic Antidepressant Drug Treatment

  2008cites this paper
• Kontinuierliche Herzfrequenzvariabilitäts-Analyse zur Beurteilung des kardialen autonomen Nervensystems nach Doxepin-Intoxikation

  2008cites this paper
• In Vivo Effect of Venlafaxine on Locus Coeruleus Neurons: Role of Opioid, α2-Adrenergic, and 5-Hydroxytryptamine1A Receptors

  2007influential citation
• Blockade of autoreceptor-mediated inhibition of norepinephrine release by atipamezole is maintained after chronic reuptake inhibition.

  2007cites this paper
• Effects of Guanfacine on Mnemonic Processing Following Lesion to Rat Medial Septum: A Novel Treatment Approach to Alzheimer's Memory Type Deficits

  2007cites this paper
• Chronic Treatment with Desipramine Improves Cognitive Performance of Rats in an Attentional Set-Shifting Test

  2007cites this paper
• Anatomical Characteristics of Norepinephrine Axons in the Prefrontal Cortex: Unexpected Findings That May Indicate Low Activity State in Naïve Animals

  2007cites this paper
• Effect of Vagus Nerve Stimulation on Serotonergic and Noradrenergic Transmission

  2006cites this paper
• Catecholaminergic strategies for the treatment of major depression.

  2006cites this paper
• Arousal, exploration and the locus coeruleus-norepinephrine system

  2006cites this paper
• The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile.

  2006influential citation
• The promises and pitfalls of reboxetine.

  2006cites this paper
• Chronic Stress Increases the Plasmalemmal Distribution of the Norepinephrine Transporter and the Coexpression of Tyrosine Hydroxylase in Norepinephrine Axons in the Prefrontal Cortex

  2006cites this paper
• Escitalopram/reboxetine combination in depressed patients with substance use disorder.

  2005cites this paper
• Chronic Reboxetine Desensitizes Terminal but not Somatodendritic α2-Adrenoceptors Controlling Noradrenaline Release in the Rat Dorsal Hippocampus

  2005influential citation
• Structural and functional models of depression: from sub‐types to substrates

  2005cites this paper
• A selective test for antidepressant treatments using rats bred for stress-induced reduction of motor activity in the swim test

  2005cites this paper
• Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety.

  2005cites this paper
• Facilitation of spontaneous glutamate release by antidepressant drugs in rat locus coeruleus.

  2005cites this paper
• Stimulant actions in rodents: implications for attention-deficit/hyperactivity disorder treatment and potential substance abuse.

  2005cites this paper
• Metabolic depression in hibernation and major depression: an explanatory theory and an animal model of depression.

  2005cites this paper
• Comparison of the effects of diazepam, the CRF1 antagonist CP-154,526 and the group II mGlu receptor agonist LY379268 on stress-evoked extracellular norepinephrine levels.

  2005cites this paper
• Pharmacogenetics and Human Molecular Genetics of Opiate and Cocaine Addictions and Their Treatments

  2005cites this paper
• The mGlu5 receptor antagonists MPEP and MTEP attenuate behavioral signs of morphine withdrawal and morphine-withdrawal-induced activation of locus coeruleus neurons in rats.

  2005cites this paper
• Correction for Gobbi et al., Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis

  2005cites this paper
• Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders.

  2004cites this paper
• Comparative study of the effects of desipramine and reboxetine on locus coeruleus neurons in rat brain slices.

  2004cites this paper
• Autoreceptor‐mediated inhibition of norepinephrine release in rat medial prefrontal cortex is maintained after chronic desipramine treatment

  2004cites this paper
• The impact of the selective monoamine reuptake inhibitors reboxetine and citalopram on visually-evoked event-related potentials in depressed patients.

  2004cites this paper
• Role of presynaptic α2-adrenoceptors in antidepressant action: recent findings from microdialysis studies

  2004cites this paper
• The Impact of the Selective Monoamine Reuptake Inhibitors Reboxetine and Citalopram on Visually-Evoked Event-Related Potentials in Depressed Patients

  2004cites this paper
• Reboxetine: A Norepinephrine Selective Reuptake Pump Inhibitor

  2004cites this paper